By crossing the RIP1-Tag2 mice with ALK1 +/− mice they further demonstrated that genetically reduced ALK1 expression retards tumor progression through the angiogenic switch, reduces de novo tumor growth, and impairs angiogenesis in this model of pancreatic islet carcinoma [96]. This evidence concerns the gene ALK and neoplasm.